Clinical Trials Browser

Phase 4 × Melanoma × Clear all

NCT07459543 2026-03-09

A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India

Phase 4 Not yet recruiting

Melanoma, Skin Neoplasms

NCT03340506 2026-02-03

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT03673332 2026-01-22

EPITOP-01

Phase 4 Terminated

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT03715205 2025-08-29

Keynote-593

Phase 4 Completed

150 enrolled 14 charts

DermatologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07092410 2025-07-29

SuRage-EB

Phase 4 Not yet recruiting

Melanoma

NCT06785974 2025-01-22

SPIRAL

Phase 4 Not yet recruiting

Melanoma, Atherosclerosis

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT06116461 2024-04-22

NIVOPTIMIZE

Phase 4 Recruiting

Melanoma

NCT01856023 2023-12-05

PROCLIVITY02

Phase 4 Terminated

29 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT03313544 2023-04-21

Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1

Phase 4 Unknown

DermatologicThoracic

Lung Neoplasms, Melanoma

NCT02068196 2023-03-24

Ipi4

Phase 4 Active not recruiting

Melanoma, Neoplasms

NCT05467137 2022-07-20

MelanooMSOT

Phase 4 Unknown

Melanoma

NCT04074460 2022-06-09

VAPOR-C

Phase 4 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms

NCT00414765 2021-06-08

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Phase 4 Completed

26 enrolled 7 charts

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT01683188 2021-02-01

PROCLIVITY01

Phase 4 Terminated

Melanoma, Skin Neoplasms

NCT04261179 2020-02-20

SENTINELSEEK

Phase 4 Unknown

BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT02451488 2020-02-10

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

Phase 4 Completed

8 enrolled 5 charts

Melanoma

NCT01898585 2020-01-07

An Open-Label Study of Zelboraf (Vemurafenib) in Patients With Braf V600 Mutation Positive Metastatic Melanoma

Phase 4 Completed

Melanoma

NCT01053819 2018-02-23

Can We Miss Pigmented Lesions in Psoriasis Patients?

Phase 4 Completed

6 enrolled 3 charts

Melanoma, Psoriasis

NCT00324272 2011-08-11

Post-Operative Drainage Following Lymph Node Dissection

Phase 4 Completed

74 enrolled 16 charts

Carcinoma, Squamous Cell, Melanoma, Seroma

NCT00075166 2008-03-04

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

Phase 4 Completed

CNSDermatologic

Brain Neoplasms, Carcinoma, Melanoma, Neoplasm Metastasis

NCT00226473 2006-06-21

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Phase 4 Unknown

Melanoma, Neoplasm Metastasis